GSK press releases
Follow
Jemperli (dostarlimab) plus chemotherapy receives positive CHMP opinion to expand approval to all adult patients with primary advanced or recurrent endometrial cancer
Positive opinion based on statistically significant and clinically meaningful progression-free and overall survival data.
